Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    15161323 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated Study of Motexafin Gadolinium With Whole Brain Radiation Therapy Followed by Stereotactic Radiosurgery Boost in the Treatment of Patients With Brain Metastases
Conditions: Neoplasm Metastasis;   Brain Neoplasms
Intervention: Drug: Motexafin gadolinium

Indicates status has not been verified in more than two years